About this trial
This single-site, randomized, blinded, placebo-controlled study will evaluate whether 4 weeks of daily Triple Support Protein powder improves glycemic control and overall well-being in healthy women aged 30-60 years. Participants will undergo baseline testing (DXA, fasting blood, standardized meal test with 2-hour glucose and insulin sampling), complete one acute supervised dose, and then consume a daily supplement for 4 weeks. During the final 14 days, participants will wear a continuous glucose monitor. Outcomes include postprandial glucose AUC, insulin sensitivity, and body composition.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Females aged 30-60 years.
BMI 18.5-40 kg/m².
Recreationally active (≥30 min/wk moderate intensity exercise).
Healthy and free from disease per health history questionnaire.
Disqualifiers
Currently supplementing whey protein.
Pregnant or nursing.
Lactose intolerant.
Currently using creatine monohydrate.
Trial design
Parallel
Treatments tested in this trial
Triple protein support
Dietary supplementPlant based protein + creatine + fiber
Placebo
Dietary supplementNon-caloric matched placebo
Treatment groups
Trial outcomes
Primary outcomes
Change in postprandial glucose area under the curve (AUC)
Glucose measured at 0-120 minutes post-meal; AUC by trapezoidal method.
Secondary outcomes
Change in insulin sensitivity (HOMA-IR)
Calculated from fasting glucose and insulin.
Change in lean soft tissue
Lean soft tissue measured from whole body dual energy x-ray absorptiometry
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of North Carolina, Chapel Hill
Lead sponsor
Perelel Inc.
Collaborator